Dr. Faridi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5125 Texoma Medical center Drive
Suite 100
Denison, TX 75020Phone+1 903-868-4700Fax+1 903-892-4910
Summary
- Dr. Amir Faridi is an oncologist in Sherman, TX and is affiliated with multiple hospitals in the area, including Wilson N. Jones Regional Medical Center, Texoma Medical Center, and Medical City McKinney. He received his medical degree from Dow University of Health Sciences and has been in practice 24 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2004
Geisinger Health SystemFellowship, Hematology and Medical Oncology, 1997 - 1998
Montefiore - Mount Vernon HospitalResidency, Internal Medicine, 1994 - 1997
Dow University of Health SciencesClass of 1993
Certifications & Licensure
TX State Medical License 1998 - 2026
OK State Medical License 2017 - 2025
CT State Medical License 1997 - 1998
PA State Medical License 1998 - 1998
WA State Medical License 1995 - 1996- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors Start of enrollment: 2023 Jun 28
- Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 Start of enrollment: 2018 Dec 26
- A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) Start of enrollment: 2023 Jan 09
Publications & Presentations
PubMed
- 6 citationsInhibition of human CD24 binding to platelet-bound P-selectin by monoclonal antibody.Chi Chen, Zili He, Padmaja Sai, Amir Faridi, Ashraf Aziz
Proceedings of the Western Pharmacology Society. 2004-01-01 - 2 citationsExtranodal rectal Hodgkin's lymphoma in an HIV-positive individual.Amir Faridi, Madhumati Kalavar, Ashraf Aziz, Zili He, William Steier
Clinical Advances in Hematology & Oncology. 2003-10-01
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
